176 related articles for article (PubMed ID: 18160532)
1. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.
Berkenstam A; Kristensen J; Mellström K; Carlsson B; Malm J; Rehnmark S; Garg N; Andersson CM; Rudling M; Sjöberg F; Angelin B; Baxter JD
Proc Natl Acad Sci U S A; 2008 Jan; 105(2):663-7. PubMed ID: 18160532
[TBL] [Abstract][Full Text] [Related]
2. Lipid lowering with thyroid hormone and thyromimetics.
Angelin B; Rudling M
Curr Opin Lipidol; 2010 Dec; 21(6):499-506. PubMed ID: 20935564
[TBL] [Abstract][Full Text] [Related]
3. The resurgence of thyromimetics as lipid-modifying agents.
Tancevski I; Eller P; Patsch JR; Ritsch A
Curr Opin Investig Drugs; 2009 Sep; 10(9):912-8. PubMed ID: 19705333
[TBL] [Abstract][Full Text] [Related]
4. Thyromimetics: a journey from bench to bed-side.
Tancevski I; Rudling M; Eller P
Pharmacol Ther; 2011 Jul; 131(1):33-9. PubMed ID: 21504761
[TBL] [Abstract][Full Text] [Related]
5. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
6. The effect of thyroid disorders on lipid levels and metabolism.
Duntas LH; Brenta G
Med Clin North Am; 2012 Mar; 96(2):269-81. PubMed ID: 22443975
[TBL] [Abstract][Full Text] [Related]
7. Thyroid mimetic as an option for lowering low-density lipoprotein.
Grundy SM
Proc Natl Acad Sci U S A; 2008 Jan; 105(2):409-10. PubMed ID: 18187579
[No Abstract] [Full Text] [Related]
8. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future.
Delitala AP; Delitala G; Sioni P; Fanciulli G
Curr Med Res Opin; 2017 Nov; 33(11):1985-1993. PubMed ID: 28498022
[TBL] [Abstract][Full Text] [Related]
9. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
10. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Gylling H; Miettinen TA
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.
Pedrelli M; Pramfalk C; Parini P
World J Gastroenterol; 2010 Dec; 16(47):5958-64. PubMed ID: 21157972
[TBL] [Abstract][Full Text] [Related]
12. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.
Tancevski I; Demetz E; Eller P
Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):16-9. PubMed ID: 21208155
[TBL] [Abstract][Full Text] [Related]
13. The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation.
Szydlowska M; Pibiri M; Perra A; Puliga E; Mattu S; Ledda-Columbano GM; Columbano A; Leoni VP
Gene Expr; 2017 Jul; 17(3):207-218. PubMed ID: 28409553
[TBL] [Abstract][Full Text] [Related]
14. The effect of taurine on cholesterol metabolism.
Chen W; Guo JX; Chang P
Mol Nutr Food Res; 2012 May; 56(5):681-90. PubMed ID: 22648615
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans.
Lind S; Rudling M; Ericsson S; Olivecrona H; Eriksson M; Borgström B; Eggertsen G; Berglund L; Angelin B
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):349-56. PubMed ID: 14656733
[TBL] [Abstract][Full Text] [Related]
16. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
17. Note on the effects of thyroidectomy and thyroid hormone administration on the concentration of bile cholesterol and cholic acid.
VAN ZYL A
J Endocrinol; 1957 Dec; 16(2):213-6. PubMed ID: 13491751
[No Abstract] [Full Text] [Related]
18. DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.
Goldman S; McCarren M; Morkin E; Ladenson PW; Edson R; Warren S; Ohm J; Thai H; Churby L; Barnhill J; O'Brien T; Anand I; Warner A; Hattler B; Dunlap M; Erikson J; Shih MC; Lavori P
Circulation; 2009 Jun; 119(24):3093-100. PubMed ID: 19506112
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.
Lin JZ; Martagón AJ; Hsueh WA; Baxter JD; Gustafsson JÅ; Webb P; Phillips KJ
Endocrinology; 2012 Dec; 153(12):6136-44. PubMed ID: 23087171
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
Sukonthasarn A; Homsanit M; Prommete B; Chotinaiwattarakul C; Piamsomboon C; Likittanasombat K
J Med Assoc Thai; 2011 Dec; 94(12):1424-34. PubMed ID: 22295727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
